Leveraging its Lightning-Link and InnovaCoat bioconjugation technologies, Innova Biosciences, Cambridge, UK, offers a line of antibodies conjugated to an extensive range of enzymes, fluorescent dyes, and colloidal gold. Designed for improved flexibility in experimental design, the line comprises 200 antibodies to nearly 30 different cardiac biomarkers, each available directly conjugated to 24 different enzymes, fluorescent dyes, or nanoparticles. In conjunction with the launch of its new line of products, Innova has also launched a new corporate website to provide customers with easier online ordering support as well as access to a range of resource materials. The website also features an antibody conjugate generator tool, which enables customers to select any desired cardiac marker, antibody clone, and label. For more information, visit Innova Biosciences.
March 3, 2014
November 13, 2017